1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Hemolysis: new trials by email Literature Review of Hemolysis trials Research Report on Hemolysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH CAN106 20 mg/kg, CAN106 40 mg/kg, CAN106 80 mg/kg - PNH, Hemolysis | Phase 1 / Phase 2 | Unknown | CARE Pharma Shanghai Ltd. | 78 | 2022-03-25 | 2022-09-14 |
Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
China (1)
Bing Han, MD (1) · Hongzhong Liu, MMed (1)